Patient population The design of this study was modeled off of our initial pilot intervention previously described7. We prospectively enrolled 70 adult patients with a diagnosis of NAFLD from our hepatology outpatient clinic in Ann Arbor, Michigan between April 2019 and March 2020. Participants were required to have imaging [ultrasound (US), Vibration controlled transient elastography (VCTE) (Fibroscan, Echosens), computed tomography (CT), or Magnetic Resonance Imaging (MRI)